NxStage Medical Inc.

439 South Union St
5th Fl
Lawrence
MA
01843
United States
(978) 687-4700
Product(s): 
Manufactures systems for the treatment of end-stage renal disease and acute kidney failure
Employees: 
170 (1221)
Ownership: 
Public
Exchange: 
NSDQ
symbol: 
NXTM
2004 Revenue: 
$1,885,000
2005 Revenue: 
$5,994,000
2006 Revenue: 
$20,812,000
2007 Revenue: 
$59,964,000
2008 Revenue: 
$128,763,000
Yahoo Quotes: 

CEO: 
Jeffrey H. Burbank, CEO/President
Management: 
Agustin M. Azel, SVP-Manufacturing
Robert S. Brown, SVP, CFO
Thomas F. Shea, SVP-Operations
Winifred L. Swan, SVP, Secretary, General Counsel
Joseph E. Turk Jr., SVP-Commercial Operations
Michael J. Webb, SVP-Quality, Regulatory & Clinical Affairs
NxStage Medical Inc.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp